Original Research

Published on 14 Sep 2022

Clinical features and prognostic factors in patients with microvascular infiltration of hepatocellular carcinoma: Development and validation of a nomogram and risk stratification based on the SEER database

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Dashuai Yang
Mingqiang Zhu
Xiangyun Xiong
Yang Su
Fangrui Zhao
Yong Hu
Guo Zhang
Junpeng Pei
Youming Ding

Frontiers in Oncology

doi 10.3389/fonc.2022.987603

2,464 views
4 citations

Case Report

Published on 13 Sep 2022

Endocrine therapy for metastatic solid pseudopapillary neoplasm of the pancreas: A case report

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Anna Kornietskaya
Sevindzh Evdokimova
Andrei Kachmazov
Alexander. Fedenko
Larisa Bolotina
Dmitriy Sidorov
Nadezhda Volchenko
Natalia Goeva
Anastasia Govaleshko
Andrey Kaprin

Frontiers in Oncology

doi 10.3389/fonc.2022.970142

2,657 views
5 citations

Original Research

Published on 13 Sep 2022

Efficacy and safety of transarterial chemoembolization combining sorafenib with or without immune checkpoint inhibitors in previously treated patients with advanced hepatocellular carcinoma: A propensity score matching analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Xue-Gang Yang
Yan-Yuan Sun
Hai-Qing Wang
De-Shan Li
Guo-Hui Xu
Xiao-Qi Huang

Frontiers in Oncology

doi 10.3389/fonc.2022.914385

2,856 views
15 citations

Original Research

Published on 13 Sep 2022

PD-1 inhibitors plus lenvatinib versus PD-1 inhibitors plus regorafenib in patients with advanced hepatocellular carcinoma after failure of sorafenib

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yongkang Xu
Shumin Fu
Kai Shang
Jiayu Zeng
Ye Mao

Frontiers in Oncology

doi 10.3389/fonc.2022.958869

2,376 views
2 citations

Original Research

Published on 12 Sep 2022

Safety and efficacy of lenvatinib combined with camrelizumab plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A two-center retrospective study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Bo Sun
Lijie Zhang
Tao Sun
Yanqiao Ren
Yanyan Cao
Weihua Zhang
Licheng Zhu
Yusheng Guo
Yuxi Gui
Fengyong Liu

Frontiers in Oncology

doi 10.3389/fonc.2022.982948

3,279 views
18 citations

Original Research

Published on 12 Sep 2022

FTO promotes liver inflammation by suppressing m6A mRNA methylation of IL-17RA

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Xiaojie Gan
Zhihui Dai
Chunmei Ge
Haozan Yin
Yuefan Wang
Jian Tan
Shuhan Sun
Weiping Zhou
Shengxian Yuan
Fu Yang

Frontiers in Oncology

doi 10.3389/fonc.2022.989353

5,060 views
20 citations

Original Research

Published on 08 Sep 2022

Identification of macrophage correlated biomarkers to predict the prognosis in patients with intrahepatic cholangiocarcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Linping Xu
Meimei Yan
Jianpeng Long
Mengmeng liu
Hui Yang
Wei Li

Frontiers in Oncology

doi 10.3389/fonc.2022.967982

4,228 views
9 citations

Original Research

Published on 06 Sep 2022

Development and validation of a 90-day mortality prediction model following endobiliary drainage in patients with unresectable malignant biliary obstruction

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Panotpol Termsinsuk
Phunchai Charatcharoenwitthaya
Nonthalee Pausawasdi

Frontiers in Oncology

doi 10.3389/fonc.2022.922386

1,928 views
3 citations

Brief Research Report

Published on 06 Sep 2022

Radiofrequency ablation in combination with CD73 inhibitor AB680 reduces tumor growth and enhances anti-tumor immunity in a syngeneic model of pancreatic ductal adenocarcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Erika Y. Faraoni
Lincoln N. Strickland
Baylee J. O’Brien
Joseph F. Barraza
Nirav C. Thosani
Curtis J. Wray
Tingting W. Mills
Jennifer M. Bailey-Lundberg

Frontiers in Oncology

doi 10.3389/fonc.2022.995027

4,006 views
7 citations

Original Research

Published on 05 Sep 2022

Prognostic value of combined inflammatory and nutritional biomarkers in HCC within the Milan criteria after hepatectomy

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Hanxin Feng
Feng Xu
Yang Zhao
Tianqiang Jin
Jianbo Liu
Rui Li
Tianyi Zhou
Chaoliu Dai

Frontiers in Oncology

doi 10.3389/fonc.2022.947302

1,596 views
5 citations

Original Research

Published on 05 Sep 2022

Neoadjuvant chemotherapy improves overall survival in resectable colorectal liver metastases patients with high clinical risk scores—— A retrospective, propensity score matching analysis

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Feng-Lin Chen
Yan-Yan Wang
Wei Liu
Bao-Cai Xing

Frontiers in Oncology

doi 10.3389/fonc.2022.973418

2,644 views
7 citations

Original Research

Published on 05 Sep 2022

Clinical course and role of embolization in patients with spontaneous rupture of hepatocellular carcinoma

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Juil Park
Yun Soo Jeong
Yun Seok Suh
Hyo-Cheol Kim
Jin Wook Chung
Jin Woo Choi

Frontiers in Oncology

doi 10.3389/fonc.2022.999557

1,342 views
5 citations

Case Report

Published on 02 Sep 2022

Complete response to talazoparib in patient with pancreatic adenocarcinoma harboring somatic PALB2 mutation: A case report and literature review

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Andrei Kachmazov
Larisa Bolotina
Anna Kornietskaya
Olesya Kuznetsova
Maxim Ivanov
Alexander Fedenko

Frontiers in Oncology

doi 10.3389/fonc.2022.953908

2,650 views
2 citations

Original Research

Published on 02 Sep 2022

Lymph node ratio is a superior predictor in surgically treated early-onset pancreatic cancer

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Yangyang Zheng
Zhenhua Lu
Xiaolei Shi
Tianhua Tan
Cheng Xing
Jingyong Xu
Hongyuan Cui
Jinghai Song

Frontiers in Oncology

doi 10.3389/fonc.2022.975846

2,643 views
3 citations

Original Research

Published on 02 Sep 2022

Effect of comprehensive cancer genomic profiling on therapeutic strategies and clinical outcomes in patients with advanced biliary tract cancer: A prospective multicenter study

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Kohichi Takada
Tomohiro Kubo
Junko Kikuchi
Makoto Yoshida
Ayako Murota
Yohei Arihara
Hajime Nakamura
Hiroyuki Nagashima
Hiroki Tanabe
Shintaro Sugita

Frontiers in Oncology

doi 10.3389/fonc.2022.988527

2,772 views
11 citations

Review

Published on 02 Sep 2022

Overcoming resistance to immune checkpoint inhibitors in hepatocellular carcinoma: Challenges and opportunities

in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers

Qingqing Xie
Pengfei Zhang
Yuanyuan Wang
Wuxuan Mei
Changchun Zeng

Frontiers in Oncology

doi 10.3389/fonc.2022.958720

3,401 views
10 citations

Navigation group

Articles

Clinical features and prognostic factors in patients with microvascular infiltration of hepatocellular carcinoma: Development and validation of a nomogram and risk stratification based on the SEER database

Endocrine therapy for metastatic solid pseudopapillary neoplasm of the pancreas: A case report

Efficacy and safety of transarterial chemoembolization combining sorafenib with or without immune checkpoint inhibitors in previously treated patients with advanced hepatocellular carcinoma: A propensity score matching analysis

PD-1 inhibitors plus lenvatinib versus PD-1 inhibitors plus regorafenib in patients with advanced hepatocellular carcinoma after failure of sorafenib

Safety and efficacy of lenvatinib combined with camrelizumab plus transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: A two-center retrospective study

FTO promotes liver inflammation by suppressing m6A mRNA methylation of IL-17RA

Identification of macrophage correlated biomarkers to predict the prognosis in patients with intrahepatic cholangiocarcinoma

Development and validation of a 90-day mortality prediction model following endobiliary drainage in patients with unresectable malignant biliary obstruction

Radiofrequency ablation in combination with CD73 inhibitor AB680 reduces tumor growth and enhances anti-tumor immunity in a syngeneic model of pancreatic ductal adenocarcinoma

Prognostic value of combined inflammatory and nutritional biomarkers in HCC within the Milan criteria after hepatectomy

Neoadjuvant chemotherapy improves overall survival in resectable colorectal liver metastases patients with high clinical risk scores—— A retrospective, propensity score matching analysis

Clinical course and role of embolization in patients with spontaneous rupture of hepatocellular carcinoma

Complete response to talazoparib in patient with pancreatic adenocarcinoma harboring somatic PALB2 mutation: A case report and literature review

Lymph node ratio is a superior predictor in surgically treated early-onset pancreatic cancer

Effect of comprehensive cancer genomic profiling on therapeutic strategies and clinical outcomes in patients with advanced biliary tract cancer: A prospective multicenter study

Overcoming resistance to immune checkpoint inhibitors in hepatocellular carcinoma: Challenges and opportunities